Physician profile
Roopa Dani
NPI 1063482180
$1,806.26
in general payments reported to CMS, 2019-2025
18 companies · $218 in 2025
The $218 reported for 2025 was more than what a typical Geriatric Medicine (Family Medicine) provider received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $149 · 2021: $186 · 2022: $275 · 2023: $455 · 2024: $378 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,052.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,051.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $400.59 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $265.30 | 2019-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $233.23 | 2019-2023 | Breztri, Farxiga |
| Novo Nordisk INC | $215.14 | 2019-2025 | Wegovy |
| Amgen INC. | $134.63 | 2020-2024 | Repatha, Otezla |
| Glaxosmithkline, LLC. | $121.71 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Lilly USA, LLC | $95.00 | 2021-2025 | Jardiance, Zepbound, Mounjaro |
| Exact Sciences Corporation | $51.11 | 2024-2025 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $50.95 | 2019 | |
| Astellas Pharma US INC | $43.08 | 2023-2025 | Veozah |
| Merck Sharp & Dohme LLC | $39.80 | 2020-2021 | |
| Tactile Systems Technology INC | $37.56 | 2023 | Entre Plus, Flexitouch Plus |
| Dexcom, INC. | $30.68 | 2024-2025 | Dexcom G6 Transmitter |
| Ultragenyx Pharmaceutical INC. | $24.49 | 2021 | |
| Novartis Pharmaceuticals Corporation | $20.28 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $16.66 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.20 | 2022 | |
| Janssen Pharmaceuticals, INC | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roopa Dani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.